GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Belluscura PLC (FRA:9VQ) » Definitions » Ending Cash Position

Belluscura (FRA:9VQ) Ending Cash Position : €3.53 Mil (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Belluscura Ending Cash Position?

Belluscura's Ending Cash Position for the quarter that ended in Jun. 2023 was €3.53 Mil.

Belluscura's quarterly Ending Cash Position declined from Jun. 2022 (€10.98 Mil) to Dec. 2022 (€1.93 Mil) but then increased from Dec. 2022 (€1.93 Mil) to Jun. 2023 (€3.53 Mil).

Belluscura's annual Ending Cash Position increased from Dec. 2020 (€0.43 Mil) to Dec. 2021 (€14.06 Mil) but then declined from Dec. 2021 (€14.06 Mil) to Dec. 2022 (€1.93 Mil).


Belluscura Ending Cash Position Historical Data

The historical data trend for Belluscura's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Belluscura Ending Cash Position Chart

Belluscura Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22
Ending Cash Position
0.47 0.93 0.43 14.06 1.93

Belluscura Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Ending Cash Position Get a 7-Day Free Trial Premium Member Only 18.80 14.06 10.98 1.93 3.53

Belluscura Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Belluscura's Ending Cash Position for the fiscal year that ended in Dec. 2022 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=14.999+-13.069
=1.93

Belluscura's Ending Cash Position for the quarter that ended in Jun. 2023 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=1.886+1.644
=3.53


Belluscura Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Belluscura's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Belluscura (FRA:9VQ) Business Description

Traded in Other Exchanges
Address
15 Fetter Lane, Holborn, London, GBR, EC4A 1BW
Belluscura PLC is a medical device company. Its first product, the X-PLOR, is a lightweight FDA-cleared portable oxygen concentrator designed to replace larger, metal oxygen tanks and heavier portable oxygen concentrator devices. The X-PLO2R weighs less than 1.5kg (3.25 lbs) and it is the first modular portable oxygen concentrator it will generate more oxygen by weight than any other FDA-cleared POC in its class. It either owns or exclusively licenses a total of 26 patents and applications relating to oxygen enrichment devices and treatments.

Belluscura (FRA:9VQ) Headlines

No Headlines